Literature DB >> 11722620

On the ontogeny and physiology of regulatory T cells.

O Annacker1, R Pimenta-Araujo, O Burlen-Defranoux, A Bandeira.   

Abstract

Lymphocytes can interfere with the activity of other lymphocytes in a thousand and one ways. A particular subset of so-called regulatory CD4+ T cells is capable of controlling the activity of other lymphocytes in yet another way. Their function is primarily defined by the ability to protect the integrity of tissues and organs in vivo. This was demonstrated in experimental models of natural tolerance to peripheral tissues, transplantation tolerance and the regulation of immune responses promoted by exogenous antigens at the level of the intestinal mucosa. Moreover, regulatory T cells also play a major role in the systemic homeostatic mechanisms that control total lymphocyte numbers. There is good evidence to support the contention that a significant fraction of the naturally occurring regulatory T cells is generated in the thymus following selection mediated by high avidity T-cell receptor/ligand interactions. Symbolically, self-reactive regulatory T cells do represent the breakthrough of concepts challenging the long-lasting Burnetian dogma that all autoreactive cells should be eliminated or inactivated. Although clonal deletion of self-reactive cells is a fundamental process in T-cell development, controlled autoreactivity is part of the physiology of the immune system. Thus, autoreactive regulatory T cells also protect immunologists from the desperate hunting for the evil of horror autotoxicus.

Mesh:

Substances:

Year:  2001        PMID: 11722620     DOI: 10.1034/j.1600-065x.2001.1820101.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  21 in total

1.  Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells.

Authors:  Helene C Dujardin; Odile Burlen-Defranoux; Laurent Boucontet; Paulo Vieira; Ana Cumano; Antonio Bandeira
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

2.  In vitro Treg suppression assays.

Authors:  Lauren W Collison; Dario A A Vignali
Journal:  Methods Mol Biol       Date:  2011

Review 3.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

4.  The sympathetic nervous system modulates CD4(+)FoxP3(+) regulatory T cells via a TGF-beta-dependent mechanism.

Authors:  Sourojit Bhowmick; Anurag Singh; Richard A Flavell; Robert B Clark; James O'Rourke; Robert E Cone
Journal:  J Leukoc Biol       Date:  2009-09-09       Impact factor: 4.962

Review 5.  Role of dendritic cells: a step forward for the hygiene hypothesis.

Authors:  Xi Yang; Xiaoling Gao
Journal:  Cell Mol Immunol       Date:  2010-11-08       Impact factor: 11.530

Review 6.  Immunity by equilibrium.

Authors:  Gérard Eberl
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

7.  A peripheral circulating compartment of natural naive CD4 Tregs.

Authors:  Danila Valmori; Andrea Merlo; Naira E Souleimanian; Charles S Hesdorffer; Maha Ayyoub
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

8.  IL-35 may maintain homeostasis of the immune microenvironment in periodontitis.

Authors:  Ying Jin; Dixin Liu; Xiaoping Lin
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447

9.  Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Authors:  Santiago Zelenay; Thiago Lopes-Carvalho; Iris Caramalho; Maria Francisca Moraes-Fontes; Manuel Rebelo; Jocelyne Demengeot
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 10.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.